|
|
The People’s Daily Online reported, on 29 September, that China now leads the world in applications for patents involving biological breeding, according to a report from the Development and Research Center of the China National Intellectual Property Administration.
Such patent applications are on the rise worldwide, but the majority come from the U.S. and, now, from China. All the top 10 applications were from Chinese universities and research institutions; the top three spots were taken by Zhejiang University, China Agricultural University and Nanjing Agricultural University. But Chinese provinces and municipalities were also listed among the applicants.
The report offered guidance to Chinese applicants in negotiating the patent process, and was not limited to biological breeding, but also included molecular marker-assisted breeding and genome-editing. That guidance was based on studies of the patents already held by transnational corporations, and how those corporations’ intellectual property rights would affect China’s molecular breeding industry.
TREND FORECAST: China is very much on the move, and as Trends Journal‘s Gerald Celente has been saying for years, “The 21st century will be the Chinese century.” It’s interesting to see China concerning itself over intellectual property rights, however, given its historical penchant for ignoring just such rights; see “CHINA CHALLENGING U.S. HI-TECH DOMINANCE” (13 Jul 2021) and “CHINA BUSINESS ESPIONAGE NETS $500 BILLION A YEAR” (29 Jun 2021).
So it’s easy to surmise that, among the many areas in which China seeks dominance, is the area of genetic engineering. The world may have already seen an example of that in COVID-19, should one choose to believe the “conspiracy theory” that the virus did not occur naturally, but was created in the Wuhan Institute of Virology, and that Dr. Anthony Fauci was complicit; see “FAUCI FUNDING OF WUHAN LAB BEING EXPOSED BY JUDICIAL WATCH” (10 Aug 2021) and “RAND PAUL LAYS DOWN LAW TO FAUCI” (20 Jul 2021).
One might also surmise that China won’t limit its genetic engineering to improving agriculture or even (allegedly) weaponizing viruses, but may delve into re-structuring human DNA, as has actually already been done, by a Chinese researcher who in 2018 used the technology called CRISPR —see “CRISPR CREATOR SAYS GENE EDITING JUST GETTING STARTED” (22 Jun 2021)—to create the world’s first gene-edited babies, albeit in violation of China’s laws; the researcher, who is not a doctor, was sentenced to three years in prison for deliberately going against China’s regulations on scientific experimentation and medical ethics; see “ARE HUMANS ALREADY BEING GENETICALLY LEGISLATED?” (8 Jun 2021).